A US-based biotech startup called Loyal has received key approval from the Food and Drug Administration (FDA) for what could be the world’s first drug, aimed at increasing the life span of dogs. The regulator’s Center for Veterinary Medicine has accepted the Reasonable Expectation of Effectiveness…
